Lamotrigina Pharma Combix (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which limits the rapid influx of sodium ions during electrical activity. This action stabilises neuronal membranes, reduces excessive firing, and decreases the release of excitatory neurotransmitters such as glutamate, thereby providing seizure control and mood‑stabilising effects.

The dose of lamotrigine is individualized by the prescribing clinician based on the patient’s age, indication, renal function, and any concomitant medications. Initiation typically starts with a low dose that is gradually increased to achieve therapeutic levels while monitoring for tolerability, especially the risk of skin reactions.

Data on lamotrigine use during pregnancy and lactation are limited. It crosses the placenta and is excreted in breast milk, so clinicians weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss individualized risk‑benefit considerations with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lamotrigine is often compared with carbamazepine or other sodium‑channel blockers. Compared with carbamazepine, lamotrigine generally has a lower risk of hyponatraemia and fewer drug‑induced liver enzyme elevations, but it requires slower titration to avoid rash. Its efficacy in seizure control is comparable, while it also offers mood‑stabilising benefits not seen with many other antiepileptics.

Lamotrigina Pharma Combix should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and ensure the packaging remains tightly closed until use. Do not store in the refrigerator or freezer.

Lamotrigine is taken orally, usually as a tablet, with or without food. The medication is swallowed whole with a full glass of water. Patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken with meals, as food does not significantly affect absorption.

The most serious risks associated with lamotrigine include severe skin reactions such as Stevens‑Johnson syndrome and toxic epidermal necrolysis, which require immediate medical attention. Other critical concerns are aseptic meningitis, blood dyscrasias like agranulocytosis, and signs of hepatic dysfunction. Prompt reporting of any rash, fever, or unusual symptoms is essential.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Patients who have previously experienced severe skin reactions (e.g., Stevens‑Johnson syndrome) to lamotrigine or related compounds should avoid its use. Caution is also advised in patients with severe renal impairment or those taking interacting medications without appropriate dose adjustments.